Comparing Lumigan vs Brimonidine Ophthalmic
Lumigan | Brimonidine ophthalmic |
|
---|
Lumigan (bimatoprost) | Brimonidine ophthalmic |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Glaucoma - Open Angle, Intraocular Hypertension. Lumigan may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Glaucoma - Open Angle, Eye Redness, Intraocular Hypertension. brimonidine ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions Glaucoma, Open Angle
Intraocular Hypertension
Popular comparisons
|
|||||||
More about Lumigan (bimatoprost) | More about Brimonidine ophthalmic | ||||||||
Ratings & Reviews | |||||||||
Lumigan has an average rating of 5.1 out of 10 from a total of 25 ratings on Drugs.com. 30% of reviewers reported a positive effect, while 39% reported a negative effect. |
Brimonidine ophthalmic has an average rating of 3.3 out of 10 from a total of 189 ratings on Drugs.com. 21% of reviewers reported a positive effect, while 72% reported a negative effect. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: Lumigan side effects in more detail. |
See also: brimonidine ophthalmic side effects in more detail. |
||||||||
Generic Availability | |||||||||
Lower cost generic |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all brimonidine ophthalmic prices |
||||||||
Dosage Form(s) Available | |||||||||
|
|
||||||||
Brand Names | |||||||||
Other bimatoprost brands include: Durysta | Alphagan P, Lumify, Lumify Preservative Free, Qoliana | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
0.75 hours |
N/A |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 7 drugs are known to interact with Lumigan:
|
A total of 357 drugs are known to interact with brimonidine ophthalmic:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
March 16, 2001 |
April 19, 2024 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.